Kite Pharma, Inc. Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 101.19 | 2,050 | 207,440 | 112,795 | 114.8 K to 112.8 K (-1.79 %) |
| Jun 27 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 100.54 | 2,950 | 296,593 | 114,845 | 117.8 K to 114.8 K (-2.50 %) |
| Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | M | 62.44 | 2,500 | 156,100 | 0 | |
| Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | M | 6.89 | 10,000 | 68,900 | 10,000 | |
| Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Sell | S | 100.60 | 12,500 | 1,257,500 | 76,250 | 88.8 K to 76.3 K (-14.08 %) |
| Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Sell | S | 100.00 | 12,500 | 1,250,000 | 88,750 | 101.3 K to 88.8 K (-12.35 %) |
| Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Buy | M | 62.44 | 2,500 | 156,100 | 101,250 | 98.8 K to 101.3 K (+2.53 %) |
| Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Buy | M | 6.89 | 10,000 | 68,900 | 98,750 | 88.8 K to 98.8 K (+11.27 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Grant | A | 0.00 | 2,410 | 0 | 66,074 | 63.7 K to 66.1 K (+3.79 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | BONDERMAN DAVID | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CLARK IAN T | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | CLARK IAN T | Director | Grant | A | 0.00 | 2,410 | 0 | 7,100 | 4.7 K to 7.1 K (+51.39 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Grant | A | 0.00 | 2,410 | 0 | 152,427 | 150 K to 152.4 K (+1.61 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Grant | A | 0.00 | 2,410 | 0 | 6,431 | 4 K to 6.4 K (+59.94 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Kazam Joshua A | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Grant | A | 0.00 | 2,410 | 0 | 4,360 | 2 K to 4.4 K (+123.59 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Grant | A | 0.00 | 2,410 | 0 | 207,836 | 205.4 K to 207.8 K (+1.17 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 2,410 | 0 | 70,374 | 68 K to 70.4 K (+3.55 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Grant | A | 0.00 | 2,410 | 0 | 88,750 | 86.3 K to 88.8 K (+2.79 %) |
| Jun 16 2017 | KITE | Kite Pharma, Inc. | Ruchefsky Steven B | Director | Sell | S | 89.48 | 20,000 | 1,789,574 | 205,426 | 225.4 K to 205.4 K (-8.87 %) |
| Jun 16 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 88.11 | 5,450 | 480,200 | 0 | 5.5 K to 0 (-100.00 %) |
| Jun 16 2017 | KITE | Kite Pharma, Inc. | CHAMPSI FARAH | Director | Sell | S | 90.40 | 15,000 | 1,356,000 | 63,664 | 78.7 K to 63.7 K (-19.07 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Option Exercise | M | 1.35 | 10,000 | 13,500 | 115,394 | |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 91.08 | 400 | 36,432 | 117,795 | 118.2 K to 117.8 K (-0.34 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 89.76 | 1,698 | 152,412 | 118,195 | 119.9 K to 118.2 K (-1.42 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 89.09 | 4,100 | 365,269 | 119,893 | 124 K to 119.9 K (-3.31 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 87.80 | 2,502 | 219,676 | 123,993 | 126.5 K to 124 K (-1.98 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 86.42 | 900 | 77,778 | 126,495 | 127.4 K to 126.5 K (-0.71 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 84.81 | 400 | 33,924 | 127,395 | 127.8 K to 127.4 K (-0.31 %) |
| Jun 12 2017 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Buy | M | 1.35 | 10,000 | 13,500 | 127,795 | 117.8 K to 127.8 K (+8.49 %) |
| Jun 09 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 84.53 | 5,000 | 422,634 | 150,017 | 155 K to 150 K (-3.23 %) |
| Jun 09 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 84.46 | 10,000 | 844,621 | 155,017 | 165 K to 155 K (-6.06 %) |
| Jun 05 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 51.43 | 2,400 | 123,432 | 50,099 | |
| Jun 05 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 72.45 | 2,400 | 173,880 | 18,664 | 21.1 K to 18.7 K (-11.39 %) |
| Jun 05 2017 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 51.43 | 2,400 | 123,432 | 21,064 | 18.7 K to 21.1 K (+12.86 %) |